The Trump administration, with Kennedy as its public health executioner, is determined to roll back decades of scientific ...
Q4 2024 Earnings Conference Call March 18, 2025 4:30 PM ETCompany ParticipantsKurt Gustafson - Chief Financial OfficerMatt ...
Company expects to have sufficient cash to fund planned operations beyond the FDA PDUFA goal date and anticipated fourth quarter 2025 launch of TNX-102 SL for fibromyalgia; $98.8 million in cash as of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback